Fideuram Asset Management (Ireland) dac
Position in RPRX — Royalty Pharma plc
CIK 2109923
DUBLIN 1, L2
Position in RPRX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$11,594,603
+$11,009,657 QoQ
Shares Held
206,788
+1595.8% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#142
of 641 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fideuram Asset Management (Ireland) dac holds $62,946,199 across 9 Biotechnology names. RPRX ranks #3 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
213,883 | $24,245,776 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
23,431 | $11,638,880 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
206,788 | $11,594,603 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
74,640 | $5,842,072 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,329 | $3,946,384 | |
| 6 | INSM |
INSMED Inc
|
29,699 | $3,166,507 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
9,390 | $1,758,559 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,059 | $619,820 |
All Filings in RPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,594,603 | 206,788 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $584,946 | 12,194 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $417,118 | 10,795 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||